Charles Roberts: Pediatric Cancer Dependencies Accelerator has already identified mechanistic, and potentially therapeutic, insights in cancers
Executive Vice President at St. Jude’s Research Hospital, shared a post by on LinkedIn, adding:
“Just over a year since our formal project launch, the Pediatric Cancer Dependencies Accelerator has already identified mechanistic, and potentially therapeutic, insights in cancers with some of the worst outcomes. A wonderful collaboration with incredible scientists! Looking forward to seeing everything we’ll be able to accomplish together.”
Quoting‘s post:
“Through the Pediatric Cancer Dependencies Accelerator, the Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute, and St. Jude Children’s Research Hospital have joined forces to leapfrog barriers in the treatment of childhood cancers to make rapid progress. Learn more in the January 2024.”
Additional details.
Source: /LinkedIn and /LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023